Lucid Diagnostics (LUCD) Total Non-Current Liabilities (2022 - 2026)
Lucid Diagnostics' (LUCD) quarterly Total Non-Current Liabilities came in at $30.1 million in Q1 2026, up 459.94% YoY from $5.4 million in Q1 2025, and up 446.02% on a QoQ basis from $5.5 million in Q4 2025.
Lucid Diagnostics (LUCD) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 5 years of Total Non-Current Liabilities data on file, last reported at $30.1 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 459.94% year-over-year to $30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.1 million (up 459.94% YoY) and the FY2025 annual result came in at $5.5 million, down 18.07% from the prior year.
- Total Non-Current Liabilities climbed to $30.1 million in Q1 2026, from $5.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $30.1 million in Q1 2026 to a low of $1.3 million in Q2 2022.
- A 5-year average of $9.4 million and a median of $6.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities jumped 1132.84% — and 2024, when it plunged 62.59%.
- Tracing LUCD's Total Non-Current Liabilities over 5 years: stood at $1.3 million in 2022, then jumped by 1119.27% to $15.6 million in 2023, then slumped by 56.98% to $6.7 million in 2024, then slipped by 18.07% to $5.5 million in 2025, then jumped by 446.02% to $30.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $30.1 million (Q1 2026), $5.5 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Lucid Diagnostics | 175.80 Mn | 142.40 Mn | 55,000.00 | 4.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.52 Mn |
| Mar 31, 2026 | 30.08 Mn |
| Dec 31, 2025 | 5.51 Mn |
| Sep 30, 2025 | 5.06 Mn |
| Jun 30, 2025 | 5.51 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | 6.72 Mn |
| Sep 30, 2024 | 6.06 Mn |
| Jun 30, 2024 | 6.93 Mn |
| Mar 31, 2024 | 7.01 Mn |
| Dec 31, 2023 | 15.63 Mn |
| Sep 30, 2023 | 16.20 Mn |
| Jun 30, 2023 | 15.81 Mn |
| Mar 31, 2023 | 12.32 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 1.46 Mn |